United Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
CEOMartine A. Rothblatt
CEOMartine A. Rothblatt
Employees1,305
Employees1,305
HeadquartersSilver Spring, Maryland
HeadquartersSilver Spring, Maryland
Founded1996
Founded1996
Employees1,305
Employees1,305
UTHR Key Statistics
Market cap19.15B
Market cap19.15B
Price-Earnings ratio16.64
Price-Earnings ratio16.64
Dividend yield—
Dividend yield—
Average volume519.20K
Average volume519.20K
High today$430.16
High today$430.16
Low today$418.36
Low today$418.36
Open price$426.40
Open price$426.40
Volume394.91K
Volume394.91K
52 Week high$459.48
52 Week high$459.48
52 Week low$266.98
52 Week low$266.98
UTHR News
Simply Wall St 6d
A Look at United Therapeutics’s Valuation After 48% Share Price RallyUnited Therapeutics (UTHR) shares have quietly outperformed the pharma and biotech sector in the past three months, gaining nearly 48%. The company’s steady rev...
Analyst ratings
71%
of 17 ratingsBuy
70.6%
Hold
29.4%
Sell
0%
People also own
Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.